Communiqués

17/08/22 Inter Pharma : New shares of IP to be traded on August 18, 2022 PU
10/08/22 Inter Pharma Public : Notification on Change of Directors and Authorization of Directors PU
10/08/22 Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5) PU
10/08/22 Inter Pharma Public : Right Adjustment of IP-W1 (Edited) PU
10/08/22 Inter Pharma Public : Right Adjustment of IP-W1 PU
10/08/22 Inter Pharma Public : Notification on the Offering Date of Newly-issued Ordinary Shares to Private Placement and Calculation of the Offering Price PU
02/08/22 Inter Pharma Public : Publication of the Minute of the Extraordinary General Meeting of Shareholders No. 1/2022 on the Company's Website PU
27/07/22 Inter Pharma Public : Report on the Utilization of Capital Increased as at June 30th, 2022 PU
22/07/22 Inter Pharma Public : Notification on the registration of the increase of the Company's registered capital PU
21/07/22 Inter Pharma Public : Notification on the registration of the reduction of the Company's registered capital PU
20/07/22 Inter Pharma Public : Resolution of the Extraordinary General Meeting of Shareholders No. 1/2022 PU
04/07/22 Inter Pharma Public : Publication of the Invitation to the Extraordinary General Meeting of Shareholders No. 1/2002 on the Company's Website PU
10/06/22 Inter Pharma Public : Postponement of the Extraordinary General Meeting of Shareholders No. 1/2022 PU
06/06/22 Inter Pharma Public : Notification the exercise of IP-W1 No. 3 PU
20/05/22 Inter Pharma Public : Schedule for the Extraordinary General Meeting of Shareholders No. 1/2022, the capital reduction and increase of registered capital, the offering of new shares to PP and Increasing Capital under General Mandate (edit) PU
01/04/22 Inter Pharma Public : Report on the results of the Exercise of IP-W1 (F53-5) PU
09/03/22 Inter Pharma Public : Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised) PU
07/03/22 Inter Pharma Public : Notification the exercise of IP-W1 PU
Aucun résultat pour cette recherche